Folate Receptor Autoantibody Test (FRAT® Test)

Early Detection - Early Intervention - Better Outcome

The early detection of folate receptor autoantibodies is necessary because it can lead to timely diagnosis and appropriate management of conditions associated with these autoantibodies. Folate receptor autoantibodies have been found in Cerebral Folate Deficiency Syndrome, Autism Spectrum Disorders, Schizophrenia, Depression and Neural Tube Defects, among other neurodevelopmental disorders.

The timely initiation of appropriate treatment, such as alternate reduced folates and/or dietary adjustments, may lead to better outcomes and improved overall prognosis for the individual.

As with any medical test, the interpretation of the results and the subsequent treatment plan should be discussed with a qualified healthcare professional.



We continuously research the significance of folate receptor autoantibodies and their implications in various neurodevelopment and neuropsychiatric disorders.

Autism Awareness